Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1959 Sep 19;2(5150):475–477. doi: 10.1136/bmj.2.5150.475

Megaloblastic Anaemia Induced by Phenylbutazone

H N Robson, J R Lawrence
PMCID: PMC1990308  PMID: 14438016

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BADENOCH J. The use of labelled vitamin B12 and gastric biopsy in the investigation of anaemia. Proc R Soc Med. 1954 Jun;47(6):426–427. [PubMed] [Google Scholar]
  2. CALVERT R. J., HURWORTH E., MACBEAN A. L. Megaloblastic anemia from methophenobarbital. Blood. 1958 Sep;13(9):894–898. [PubMed] [Google Scholar]
  3. CHANARIN I., ELMES P. C., MOLLIN D. L. Folic-acid studies in megaloblastic anaemia due to primidone. Br Med J. 1958 Jul 12;2(5088):80–82. doi: 10.1136/bmj.2.5088.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ENGLEMAN E. P., KRUPP M. A., RINEHART J. F., JONES R. C., GIBSON J. R. Hepatitis following the ingestion of phenylbutazone. J Am Med Assoc. 1954 Sep 11;156(2):98–101. doi: 10.1001/jama.1954.02950020004002. [DOI] [PubMed] [Google Scholar]
  5. GIRDWOOD R. H., LENMAN J. A. Megaloblastic anaemia occurring during primidone therapy. Br Med J. 1956 Jan 21;1(4959):146–147. doi: 10.1136/bmj.1.4959.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GYDELL K. Megaloblastic anaemia in patients treated with diphenylhydantoin and primidone. Acta Haematol. 1957 Jan;17(1):1–15. doi: 10.1159/000205202. [DOI] [PubMed] [Google Scholar]
  7. HAWKINS C. F., MEYNELL M. J. Megaloblastic anaemia due to phenytoin sodium. Lancet. 1954 Oct 9;267(6841):737–738. doi: 10.1016/s0140-6736(54)90499-7. [DOI] [PubMed] [Google Scholar]
  8. HODGE P. R., LAWRENCE J. R. Two cases of myocarditis associated with phenylbutazone therapy. Med J Aust. 1957 May 11;44(19):640–641. doi: 10.5694/j.1326-5377.1957.tb57555.x. [DOI] [PubMed] [Google Scholar]
  9. MACCARTHY J. M., JACKSON R. T. Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy. Br Med J. 1955 Jul 23;2(4933):240–242. doi: 10.1136/bmj.2.4933.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. NEWMAN M. J., SUMNER D. W. Megaloblastic anemia following the use of primidone. Blood. 1957 Feb;12(2):183–188. [PubMed] [Google Scholar]
  11. O'BRIEN D. J., STOREY G. Death from hypersensitivity due to phenylbutazone. Br Med J. 1954 Apr 3;1(4865):792–794. doi: 10.1136/bmj.1.4865.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. STEINBERG C. L., BOHROD M. G., ROODENBURG A. I. Agranulocytosis following phenylbutazone (butazolidin) therapy; report of a fatal case. J Am Med Assoc. 1953 May 2;152(1):33–36. doi: 10.1001/jama.1953.63690010009007g. [DOI] [PubMed] [Google Scholar]
  13. STOKES J. B., FORTUNE C. Megaloblastic anaemia associated with anticonvulsant drug therapy. Australas Ann Med. 1958 May;7(2):118–125. doi: 10.1111/imj.1958.7.2.118. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES